Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026Sidley Advises on the Hong Kong IPO of Shenzhen SDMC TechnologyMay 27, 2026Sidley Represents Peach Finance in Its Acquisition by SoFiMay 26, 2026Sidley Advises UISEE Technologies on Its Successful Chapter 18C Listing in Hong KongMay 20, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory